Haematological Disease

Haematological Disease

عرض إصدارات أخرى (1)

Patients with haematological diseases are major users of blood components. This chapter focuses on bone marrow failure syndromes and stem cell transplantation, in addition to haematological malignancies. The transfusion support of patients with haematological disease may be complex and includes the...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Estcourt, L, Stanworth, S, Murphy, M
التنسيق:	Book section
منشور في:	John Wiley and Sons 2013

مواد مشابهة

Haematological Disease
حسب: Murphy, M, وآخرون
منشور في: (2009)

Platelet transfusions for patients with haematological malignancies: who needs them?
حسب: Estcourt, L, وآخرون
منشور في: (2011)

Intracranial haemorrhage in thrombocytopenic haematology patients—a nested case–control study: the InCiTe study protocol
حسب: Estcourt, L, وآخرون
منشور في: (2014)

Intracranial hemorrhage in patients with haematological malignancy, a nested case-control study
حسب: Estcourt, L, وآخرون
منشور في: (2017)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
حسب: Estcourt, L, وآخرون
منشور في: (2016)

Anti-fibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders (Protocol)
حسب: Wardrop, D, وآخرون
منشور في: (2016)

Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological malignancies (Review).
حسب: Wardrop, D, وآخرون
منشور في: (2013)

Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
حسب: Desborough, M, وآخرون
منشور في: (2016)

Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
حسب: Estcourt, L, وآخرون
منشور في: (2012)

Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation
حسب: Estcourt, L, وآخرون
منشور في: (2014)

Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
حسب: Estcourt, L, وآخرون
منشور في: (2015)

Prophylactic platelet transfusions
حسب: Estcourt, L, وآخرون
منشور في: (2010)

Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation
حسب: Estcourt, L, وآخرون
منشور في: (2016)

Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
حسب: Estcourt, L, وآخرون
منشور في: (2015)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- The ATHENA study
حسب: Estcourt, L, وآخرون
منشور في: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (Protocol).
حسب: Estcourt, L, وآخرون
منشور في: (2014)

Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
حسب: Estcourt, L, وآخرون
منشور في: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.
حسب: Estcourt, L, وآخرون
منشور في: (2014)

Prospective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies‐ The ATHENA study
حسب: Estcourt, L, وآخرون
منشور في: (2014)

Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.
حسب: Stanworth, S, وآخرون
منشور في: (2006)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation (protocol)
حسب: Estcourt, L, وآخرون
منشور في: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: A subgroup analysis of a randomized trial (CME)
حسب: Stanworth, S, وآخرون
منشور في: (2014)

Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.
حسب: Stanworth, S, وآخرون
منشور في: (2014)

2016 National audit of red cell use in adult haematology patients
حسب: Karakantza, M, وآخرون
منشور في: (2017)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
حسب: Crighton, GL, وآخرون
منشور في: (2015)

Pathogen-reduced platelets for the prevention of bleeding (protocol)
حسب: Butler, C, وآخرون
منشور في: (2011)

A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
حسب: Crighton, GL, وآخرون
منشور في: (2021)

Pathogen-reduced platelets for the prevention of bleeding (Review)
حسب: Estcourt, L, وآخرون
منشور في: (2017)

Is sepsis a risk factor for bleeding in adults with hematologic malignancies?
حسب: Estcourt, L, وآخرون
منشور في: (2017)

Pathogen-reduced platelets for the prevention of bleeding (Review)
حسب: Butler, C, وآخرون
منشور في: (2013)

Pathogen-reduced platelets for the prevention of bleeding.
حسب: Butler, C, وآخرون
منشور في: (2013)

Transfusion practice and safety: current status and possibilities for improvement.
حسب: Murphy, M, وآخرون
منشور في: (2011)

Can you see the wood for the trees? Making sense of forest plots in systematic reviews 2. Analysis of the combined results from the included studies.
حسب: Hyde, C, وآخرون
منشور في: (2008)

Evidence for indications of fresh frozen plasma.
حسب: Stanworth, S, وآخرون
منشور في: (2007)

Can you see the wood for the trees? Making sense of forest plots in systematic reviews.
حسب: Hyde, C, وآخرون
منشور في: (2008)

Prophylactic platelet transfusions in patients with blood malignancies: Cost analysis of a randomized trial
حسب: Campbell, H, وآخرون
منشور في: (2014)

Prophylactic platelet transfusions in patients with blood malignancies: cost analysis of a randomized trial.
حسب: Campbell, H, وآخرون
منشور في: (2014)

Platelet transfusions in haematology patients: are we using them appropriately?
حسب: Estcourt, L, وآخرون
منشور في: (2012)

Alternatives to allogeneic platelet transfusion
حسب: Desborough, M, وآخرون
منشور في: (2016)

Putting clinical trials into context.
حسب: Hyde, C, وآخرون
منشور في: (2005)